10-73177859-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173348.2(FAM149B1):āc.166A>Gā(p.Thr56Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,551,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173348.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM149B1 | NM_173348.2 | c.166A>G | p.Thr56Ala | missense_variant | 3/14 | ENST00000242505.11 | NP_775483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM149B1 | ENST00000242505.11 | c.166A>G | p.Thr56Ala | missense_variant | 3/14 | 5 | NM_173348.2 | ENSP00000242505.6 | ||
FAM149B1 | ENST00000372955.7 | c.-15A>G | upstream_gene_variant | 1 | ENSP00000362046.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000127 AC: 2AN: 157530Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83240
GnomAD4 exome AF: 0.0000350 AC: 49AN: 1399354Hom.: 0 Cov.: 30 AF XY: 0.0000406 AC XY: 28AN XY: 690180
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2023 | The c.166A>G (p.T56A) alteration is located in exon 3 (coding exon 3) of the FAM149B1 gene. This alteration results from a A to G substitution at nucleotide position 166, causing the threonine (T) at amino acid position 56 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at